Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Sharad Mansukani Insider Profile

4 Followers

Sharad Mansukani, Director at Agilon Health, holds 56.24K shares in Agilon Health (Ticker: AGL), holds 71.52K shares in Endo International (Ticker: ENDPQ), holds 0.00 shares in Kindred Healthcare (Ticker: KND).

Sharad Mansukani's Trading History

AGLAgilon Health		Jun 04, 2026DirectorUninformative Buy―$6.38M
ENDPQEndo International		Jun 14, 2019―Uninformative Buy―$858.28
KNDKindred Healthcare		Jul 02, 2018―Uninformative Sell346.61K$0.00
SCAISurgical Care		Mar 24, 2017―Uninformative Sell―$465.29K
CNVYConvey Holding Parent		――――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Sharad Mansukani insider profile FAQ

What is the percentage of profitable transactions made by Sharad Mansukani?
The percentage of profitable transactions made by Sharad Mansukani is 50%.
What is the average return per transaction made by Sharad Mansukani?
The average return per transaction made by Sharad Mansukani is -4.20%.
What stocks does Sharad Mansukani hold?
Sharad Mansukani holds: AGL, ENDPQ, SCAI, CNVY, KND stocks.
What was Sharad Mansukani's most profitable transaction?
Sharad Mansukani’s most profitable transaction was an Informative Sell of AGL stock on September 15, 2021. The return on the trade was 19.50%.
What is Sharad Mansukani's role in Agilon Health?
Sharad Mansukani's role in Agilon Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.